ArticleFrontiers in endocrinology2026
Identifying risk factors for vasculogenic etiology in patients with erectile dysfunction based on clinical features and machine learning.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Vasculogenic erectile dysfunction (ED) is an important subtype of organic ED, and its development and progression are closely related to endocrine, metabolic, and psychological factors. Identifying risk factors for vasculogenic ED may facilitate early recognition and targeted intervention. Methods: This study included 519 patients diagnosed with ED using penile color Doppler duplex ultrasonography (CDDU) as the gold standard. Clinical and laboratory indicators were collected. Feature selection was strictly performed within the training set using univariate logistic regression, the Boruta algorithm, and least absolute shrinkage and selection operator (LASSO) regression. Based on the selected key variables, five machine learning models-logistic regression, random forest, support vector machine, light gradient boosting machine (LightGBM), and extreme gradient boosting (XGBoost)-were constructed and compared. Model performance was evaluated using metrics including the area under the receiver operating characteristic curve (AUC), and the SHapley Additive exPlanations (SHAP) method was employed to interpret the optimal model. Results: Among the 519 patients, 235 were diagnosed with vasculogenic ED. Feature selection identified seven key risk factors: age, hypertension, smoking, diabetes, Hamilton Anxiety Scale (HAMA) score, total testosterone (T), and estradiol (E2). The random forest model performed best in the validation set, but its discriminative ability was only moderate (AUC = 0.682, 95% confidence interval [CI]: 0.598-0.768). SHAP analysis revealed that age contributed most to the model predictions, followed by hypertension, T, and smoking; the HAMA score also ranked highly. Testosterone levels exhibited a nonlinear U-shaped association with vasculogenic ED risk. Conclusion: Based on routine clinical indicators, this study identified seven key factors associated with vasculogenic ED. Among them, anxiety as measured by the HAMA score was recognized as a non-traditional factor, suggesting a complex interplay between psychological factors and vascular pathology; however, the specific direction of this relationship remains to be elucidated by prospective studies. The machine learning model constructed in this study showed moderate discriminative ability and is currently insufficient to support independent clinical decision-making. Future research should collect multicenter, large-sample data and adjust model parameters for further validation and optimization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.